Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmon... Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition and pending Forty-Seven acquisition boost Gilead's exposure to cell therapy and noncell therapy in oncology. Mehr anzeigen
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conference: J.P. Morgan Healthcare Conference on Monday, January 13, 2025...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Trodelvy® (sacituzumab govitecan-hziy) for...
-- Gilead and Terray Will Leverage Terray’s tNova Drug Discovery Platform to Identify Small Molecule Therapeutics Against Targets of Interest -- -- Gilead Has Exclusive Option to Develop and...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.24 | -0.259123299503 | 92.62 | 94.55 | 91.79 | 3299588 | 93.89182287 | CS |
| 4 | -0.27 | -0.291419320022 | 92.65 | 94.65 | 89.15 | 7269309 | 92.37116698 | CS |
| 12 | 7.33 | 8.61845972957 | 85.05 | 98.9 | 84.165 | 6580600 | 90.87127798 | CS |
| 26 | 23.72 | 34.5470434023 | 68.66 | 98.9 | 66.01 | 6500767 | 83.77320194 | CS |
| 52 | 11.47 | 14.1762452107 | 80.91 | 98.9 | 62.07 | 7063182 | 77.36372261 | CS |
| 156 | 18.7165 | 25.4081057783 | 73.6635 | 98.9 | 57.165 | 7145829 | 73.72853348 | CS |
| 260 | 26.65 | 40.5446523657 | 65.73 | 98.9 | 56.56 | 8428293 | 71.73667086 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
